Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 03.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
03.06.24Fangdd Network Group Ltd: FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary General Meeting of Shareholders151SHENZHEN, China, June 03, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) ("FangDD" or the "Company") today announced that the Company and The Bank of New York Mellon intend to terminate...
► Artikel lesen
03.06.24Ekobot finalises the sale of the Company's business204Ekobot AB (publ) ("Ekobot" or the "Company") announces today that the Company has completed the sale to HH Agriculture Investments B.V. (the "Buyer") of the Company's business. The Buyer has acceded...
► Artikel lesen
03.06.24National Bankshares, Inc. Completes Acquisition of Frontier Community Bank276BLACKSBURG, Va., June 03, 2024 (GLOBE NEWSWIRE) -- National Bankshares, Inc. (Nasdaq: NKSH - "National Bankshares" or the "Company"), the holding company for The National Bank of Blacksburg ("National...
► Artikel lesen
03.06.24Canadian GoldCamps Corp.: Canadian GoldCamps Enters into Definitive Agreement to Acquire 70% interest in Murphy Lake Property located in the Athabasca Basin, Saskatchewan227VANCOUVER, British Columbia and TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Canadian GoldCamps Corp. ("Canadian GoldCamps", or the "Company") (CSE: CAMP) (FSE: A68) (OTC: SMATF) announces that further...
► Artikel lesen
03.06.24American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer290FORT MYERS, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation's fastest-growing community oncology networks, today announced the appointment...
► Artikel lesen
03.06.24Ingersoll Rand Closes on ILC Dover and Announces Acquisition of Three Additional Companies321Extends portfolio in sustainable end markets, including life sciences, food and beverage, medical, and wastewater treatmentDemonstrates company's commitment to capital allocation and achievement of...
► Artikel lesen
03.06.24Zapata Computing, Inc.: Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)237BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Zapata Computing Holdings Inc. ("Zapata AI" or the "Company") (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that the Compensation...
► Artikel lesen
03.06.24Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)173FOSTER CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small...
► Artikel lesen
03.06.24Structure Therapeutics Inc.: Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants247SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
► Artikel lesen
03.06.24Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)128REDWOOD CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development...
► Artikel lesen
03.06.24Safe Bulkers, Inc. Announces Agreement for the Acquisition of One Japanese Kamsarmax Class Dry-bulk Vessel202MONACO, June 03, 2024 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it has entered into...
► Artikel lesen
03.06.24GitLab Inc.: GitLab Reports First Quarter Fiscal Year 2025 Financial Results186First Quarter Fiscal Year 2025 Highlights: Total revenue of $169.2 million, up 33% year-over-yearSignificant year-over-year GAAP and Non-GAAP operating margin expansionOperating cash flow of $38.1...
► Artikel lesen
03.06.24Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination76New York, June 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today that it has elected...
► Artikel lesen
03.06.24Lavoro Limited: Lavoro Reports Fiscal Third Quarter 2024 Earnings Results5203Q24 revenue grew 6% to $514.2 million. Growth was driven by continued market share gains and volume growth, which mitigated ongoing deflation in input prices throughout Brazil and Colombia.Gross...
► Artikel lesen
03.06.24X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)125BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
► Artikel lesen
03.06.24Dave Inc.: Dave Extends its Partnership with Drew League, LA's Pro-Am Basketball League157LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- Dave (NASDAQ: DAVE), one of the nation's leading neobanks, announced an extension of its official partnership with the Drew League, Los Angeles' premiere...
► Artikel lesen
03.06.24FibroGen, Inc.: FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO in Upcoming Clinical Trials170FibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to...
► Artikel lesen
03.06.24Spero Therapeutics, Inc.: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)165CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments...
► Artikel lesen
03.06.24FibroGen, Inc.: FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors275The safety and efficacy of FG-3165 will be evaluated in a Phase 1 trial in select solid tumorsPlan to begin enrollment in 2H 2024 SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:...
► Artikel lesen
03.06.24Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024144- Participants from the completed Phase 2 hypothalamic obesity trial reported positive changes in sleep, energy levels during setmelanotide therapy in qualitative interviews - - Separate analysis...
► Artikel lesen
Seite:  Weiter >>